Fate Therapeutics Inc. buy EF Hutton Acquisition Co. I
Start price
01.03.23
/
50%
€5.72
Target price
01.03.24
€9.37
Performance (%)
26.81%
End price
02.03.24
€7.25
Summary
This prediction ended on 02.03.24 with a price of €7.25. The prediction had a final performance of 26.81%. EF_Hutton_Acquisitio has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | -17.926% | -17.926% | 81.350% | -47.016% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by EF_Hutton_Acquisitio for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $10.00 price target on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von EF_Hutton_Acquisitio gewählte maximale Laufzeit wurde überschritten